STVN Stevanato Group S.p.A.
STVN Stevanato Group S.p.A.
Healthcare · Medical Instruments & Supplies
Market read
POC $15.66 · VWAP $18.87 · +12.7% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
STVN Price Structure
Loading timeframes…
Peers
Every watchlist STVN belongs to, members best 30-day change first — STVN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-glp1-manufacturing
Against street estimates
How STVN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about STVN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 111 days ago · Apr 29 · last pull reported an error, so these may be older than they look
- Stevanato Group S.p.A. (STVN) Latest Stock News & Headlines
- Stevanato Group: STVN Stock Price Quote & News - Robinhood
- Stevanato Group S.p.A. (STVN) Stock Price, News & Analysis - MarketBeat
- Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
- Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decrease in Short Interest
STVN research tape
2 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.